Hologic to be Acquired by Blackstone and TPG

TL;DR

Hologic selling to Blackstone & TPG - deal announced Nov 5, 2025.

AI Summary

Hologic, Inc. announced on November 5, 2025, that it is being acquired by Blackstone and TPG. This announcement was made via an internal FAQ distributed to employees, indicating a significant change in the company's ownership structure.

Why It Matters

This acquisition by private equity firms Blackstone and TPG signifies a major shift in Hologic's corporate structure and future strategic direction, potentially impacting its operations and market position.

Risk Assessment

Risk Level: medium — Acquisitions by private equity can lead to significant operational changes, debt restructuring, and potential divestitures, creating uncertainty for employees and investors.

Key Players & Entities

• Hologic, Inc. (company) — Company being acquired
• Blackstone (company) — Acquiring firm
• TPG (company) — Acquiring firm
• November 5, 2025 (date) — Date of announcement

FAQ

Filing Documents

• d58248ddefa14a.htm (DEFA14A) — 36KB
• 0001193125-25-266988.txt ( ) — 37KB

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Hologic, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-(6)(i)(1) and 0-11 On November 5, 2025, Hologic, Inc. shared the following internal FAQ with its employees. HOLOGIC TO BE ACQUIRED BY BLACKSTONE AND TPG 1. Why are we selling the company? We believe this is an excellent opportunity for Hologic as a whole, and more specifically for our stockholders, employees, customers and patients. Hologic is well positioned for success as a private company, given our large businesses in stable, established sectors, and our strong profitability, cash flows and balance sheet. With Blackstone and TPG, Hologic will be even better positioned globally, with fewer capital constraints and expanded resources to invest in growth and innovation. 2. What is the rationale for the transaction? Upon closing, Hologic will become a private company with enhanced flexibility and resources to accelerate growth and strengthen our leadership in women's health globally. Blackstone and TPG will enhance our ability to deliver critical medical technologies that benefit customers and patients. The transaction delivers immediate and compelling value to Hologic stockholders. 3. How did the transaction come about? Leaders from Blackstone and TPG told us they have been following Hologic's progress for many years. A detailed history of the transaction will be included in Hologic's proxy statement, which will be filed with the SEC and be publicly available in the coming weeks. 4. Who are Blackstone and TPG? Blackstone and TPG are two of the world's most respected investment firms. Each has a long and successful track record of partnering with innovative healthcare companies to support their missions and enable growth. 5. What approvals are needed? When is the acquisition expected to be final? The Hologic Board of Directors unanimously approved the merger agreement and recommends that stockholders approve the transaction and adopt the merger agreement. The transaction is expected to close in the first half of calendar 2026, subject to the approval of Hologic stockholders, the receipt of various required regulatory approvals, and other customary closing conditions. 6. Will Hologic remain listed on the Nasdaq stock market? Upon completion of the transaction, Hologic's common stock will be delisted from Nasdaq and we will become a private company owned by Blackstone and TPG. 7. Will Hologic continue to operate with the same name following closing? The Company will continue to operate under the Hologic name and brand. 8. How will this affect company culture? Blackstone and TPG have spent considerable time meeting with management and discussing our unique culture, including our engagement results. We firmly believe their cultures and approaches are squarely aligned with ours—they are each excited about the chance to partner with us and work with our highly talented teams. They know that our company culture – which is owned by our people – contributes significantly to our success. Blackstone and TPG are fully committed to supporting our Purpose, Passion and Promise. They believe our Company, our people and our products play an indispensable role in advancing women's health. 9. How will this transaction affect our jobs overall? Until closing, Hologic will continue to run its business as usual, operating independently from Blackstone and TPG. For the vast majority of employees, we expect this change to be seamless, for day-to-day jobs to remain largely the same, and for this to be a long-term positive. Blackstone and TPG's operating model is to partner with management teams to improve results. In addition, a key near-term priority for Blackstone and TPG will be continuity – specifically maintaining consistent production and sales of existing products, as well as excellent customer relationships. 10. Are we allowed to trade Hologic stock freely before the transaction closes? For most employees, nothing has changed with respect to your ability to trade. But everyone is still subject to our trading policy, which prohibits trading on material, non-public information, among other things. Employees who are more directly involved wit

View Full Filing

View this DEFA14A filing on SEC EDGAR